FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Leszek Tylicki

Research Profile

Chemicals & Drugs

Procedures

Disorders

Anatomy

Concepts & Ideas

Co-author Network

Publications

TOP 3
Marcin Renke; Narcyz Knap; Slawomir Lizakowski; Przemysław Rutkowski; Leszek Tylicki; Michał Woźniak; Bolesław Rutkowski
[Isoprostanes - important marker of the oxidative stress estimation in patients with chronic kidney disease].
Slawomir Lizakowski; Wieslawa Łysiak-Szydłowska; Marcin Renke; Ewa Aleksandrowicz; Zbigniew Heleniak; Przemysław Rutkowski; Maja Sławińska-Morawska; Leszek Tylicki; Bolesław Rutkowski
Effect of aliskiren on proteinuria in non-diabetic chronic kidney disease: a double-blind, crossover, randomised, controlled trial.
Leszek Tylicki; Slawomir Lizakowski; Boleslaw Rutkowski
Renin-angiotensin-aldosterone system blockade for nephroprotection: current evidence and future directions.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Leszek Tylicki (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Marcin Renke; Narcyz Knap; Slawomir Lizakowski; Przemysław Rutkowski; Leszek Tylicki; Michał Woźniak; Bolesław Rutkowski
[Isoprostanes - important marker of the oxidative stress estimation in patients with chronic kidney disease].
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 2013;34(199):14-7.
2012: Slawomir Lizakowski; Wieslawa Łysiak-Szydłowska; Marcin Renke; Ewa Aleksandrowicz; Zbigniew Heleniak; Przemysław Rutkowski; Maja Sławińska-Morawska; Leszek Tylicki; Bolesław Rutkowski
Effect of aliskiren on proteinuria in non-diabetic chronic kidney disease: a double-blind, crossover, randomised, controlled trial.
International urology and nephrology 2012;44(6):1763-70.
2012: Leszek Tylicki; Slawomir Lizakowski; Boleslaw Rutkowski
Renin-angiotensin-aldosterone system blockade for nephroprotection: current evidence and future directions.
Journal of nephrology 2012;25(6):900-10.
2012: Slawomir Lizakowski; Sylwia Małgorzewicz; Marcin Renke; Ewa Aleksandrowicz-Wrona; Zbigniew Heleniak; Przemysław Rutkowski; Maja Sławińska-Morawska; Leszek Tylicki; Bolesław Rutkowski
Aliskiren and perindopril reduce the levels of transforming growth factor-β in patients with non-diabetic kidney disease.
American journal of hypertension 2012;25(6):636-9.
2012: Leszek Tylicki; Przemysław Rutkowski; Beata Sulikowska; Rafał Bednarski; Rafał Donderski; Zbigniew Heleniak; Slawomir Lizakowski; Jacek Manitius; Milena Przybylska; Marcin Renke; Bolesław Rutkowski
The enhanced renin-angiotensin-aldosteron system pharmacological blockade--which is the best?.
Kidney & blood pressure research 2012;36(1):335-43.
2010: Marcin Renke; Leszek Tylicki; Przemyslaw Rutkowski; Wojciech Larczynski; Alexander Neuwelt; Ewa Aleksandrowicz; Wiesława Łysiak-Szydłowska; Boleslaw Rutkowski
The effect of N-acetylcysteine on blood pressure and markers of cardiovascular risk in non-diabetic patients with chronic kidney disease: a placebo-controlled, randomized, cross-over study.
Medical science monitor : international medical journal of experimental and clinical research 2010;16(7):PI13-8.
2010: Marcin Renke; Przemyslaw Rutkowski; Leszek Tylicki; Boleslaw Rutkowski
Combination treatment and renal function in patients with chronic kidney disease.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2010;11(2):146-7.
2010: Marcin Renke; Narcyz Knap; Leszek Tylicki; Przemyslaw Rutkowski; Alexander Neuwelt; Wojciech Larczynski; Michal Wozniak; Boleslaw Rutkowski
Atorvastatin attenuates oxidative stress in patients with chronic kidney disease.
Medical science monitor : international medical journal of experimental and clinical research 2010;16(3):LE3-3.
2010: Marcin Renke; Leszek Tylicki; Przemyslaw Rutkowski; Alexander Neuwelt; Wojciech Larczyński; Marcin Ziętkiewicz; Ewa Aleksandrowicz; Wiesława Lysiak-Szydłowska; Boleslaw Rutkowski
Atorvastatin improves tubular status in non-diabetic patients with chronic kidney disease - placebo controlled, randomized, cross-over study.
Acta biochimica Polonica 2010;57(4):547-52.
2010: Marcin Renke; Leszek Tylicki; Przemyslaw Rutkowski; Narcyz Knap; Marcin Zietkiewicz; Alexander Neuwelt; Ewa Aleksandrowicz; Wiesława Łysiak-Szydłowska; Michał Woźniak; Boleslaw Rutkowski
Effect of pentoxifylline on proteinuria, markers of tubular injury and oxidative stress in non-diabetic patients with chronic kidney disease - placebo controlled, randomized, cross-over study.
Acta biochimica Polonica 2010;57(1):119-23.
2009: Marcin Renke; Leszek Tylicki; Narcyz Knap; Przemyslaw Rutkowski; Alexander Neuwelt; Andriy Petranyuk; Wojciech Larczynski; Michał Wozniak; Boleslaw Rutkowski
High-dose angiotensin-converting enzyme inhibitor attenuates oxidative stress in patients with chronic kidney disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009;24(2):689-90.
2008: Marcin Renke; Leszek Tylicki; Narcyz Knap; Przemyslaw Rutkowski; Alexander Neuwelt; Wojciech Larczynski; Michal Wozniak; Boleslaw Rutkowski
Spironolactone attenuates oxidative stress in patients with chronic kidney disease.
Hypertension 2008;52(5):e132-3; author reply e134.
2008: Leszek Tylicki; Przemyslaw Rutkowski; Marcin Renke; Wojciech Larczyński; Ewa Aleksandrowicz; Wieslawa Lysiak-Szydlowska; Boleslaw Rutkowski
Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2008;52(3):486-93.
2008: Leszek Tylicki; Marcin Renke; Przemysław Rutkowski; Wojciech Larczyński; Ewa Aleksandrowicz; Wieslawa Lysiak-Szydlowska; Boleslaw Rutkowski
Dual blockade of the renin-angiotensin-aldosterone system with high-dose angiotensin-converting enzyme inhibitor for nephroprotection: an open, controlled, randomized study.
Scandinavian journal of urology and nephrology 2008;42(4):381-8.
2008: Marcin Renke; Leszek Tylicki; Przemyslaw Rutkowski; Wojciech Larczyński; Ewa Aleksandrowicz; Wiesława Lysiak-Szydłowska; Boleslaw Rutkowski
The effect of N-acetylcysteine on proteinuria and markers of tubular injury in non-diabetic patients with chronic kidney disease. A placebo-controlled, randomized, open, cross-over study.
Kidney & blood pressure research 2008;31(6):404-10.
2008: Marcin Renke; Przemysław Rutkowski; Leszek Tylicki; Marcin Zietkiewicz; Wojciech Larczyński; Boleslaw Rutkowski
[Pentoxifylline old drug or new hope for nephrology?].
Przegla̧d lekarski 2008;65(7-8):358-61.
2008: Marcin Renke; Przemysław Rutkowski; Leszek Tylicki; Marcin Zietkiewicz; Wojciech Larczyński; Boleslaw Rutkowski
[Clinical state of a patient with nephrotic proteinuria successfully treated with combined therapy with angiotensin II receptor antagonists and angiotensin II converting enzyme inhibitors and pentoxifylline].
Przegla̧d lekarski 2008;65(6):312-4.
2008: Leszek Tylicki; Marcin Renke; Przemyslaw Rutkowski; Wojciech Larczynski; Ewa Aleksandrowicz; Wieslawa Lysiak-Szydlowska; Boleslaw Rutkowski
Effects of N-acetylcysteine on angiotensin-converting enzyme plasma activity in patients with chronic kidney diseases.
Blood purification 2008;26(4):354.
2007: Leszek Tylicki; Przemyslaw Rutkowski; Marcin Renke; Boleslaw Rutkowski
Addition of aldosterone receptor blocker to dual renin-angiotensin-aldosterone blockade leads to limitation of tubulointerstitial injury of kidney.
Kidney international 2007;72(9):1164-5.
2007: Leszek Tylicki; Bogdan Biedunkiewicz; Andrzej Chamienia; Klaudiusz Wojnarowski; Zbigniew Zdrojewski; Ewa Aleksandrowicz; Wieslawa Lysiak-Szydlowska; Boleslaw Rutkowski
Renal allograft protection with angiotensin II type 1 receptor antagonists.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007;7(1):243-8.
2006: Bogdan Biedunkiewicz; Slawomir Lizakowski; Leszek Tylicki; Anna Skiboeska; Tomasz Nieweglowski; Andrzej Chamienia; Alicja Debska-Slizien; Boleslaw Rutkowski
Blood coagulation unaffected by ozonated autohemotherapy in patients on maintenance hemodialysis.
Archives of medical research 2006;37(8):1034-7.
2006: Leszek Tylicki; Bogdan Biedunkiewicz; Andrzej Chamienia; Klaudiusz Wojnarowski; Zbigniew Zdrojewski; Boleslaw Rutkowski
Randomized placebo-controlled study on the effects of losartan and carvedilol on albuminuria in renal transplant recipients.
Transplantation 2006;81(1):52-6.
2006: Leszek Tylicki; Heidi Puttinger; Przemyslaw Rutkowski; Boleslaw Rutkowski; Walter H Horl
Smoking as a risk factor for renal injury in essential hypertension.
Nephron. Clinical practice 2006;103(4):c121-8.
2006: Leszek Tylicki; Heidi Puttinger; Przemyslaw Rutkowski; Tomasz Nieweglowski; Boleslaw Rutkowski; Walter H Hörl
Multifactoral analysis of determinators for renal injury in essential hypertension.
Journal of human hypertension 2006;20(1):93-5.
2005: Leszek Tylicki; Manuela Födinger; Heidi Puttinger; Przemyslaw Rutkowski; Pawel Strozecki; Sylwia Tyszko; Boleslaw Rutkowski; Walter H Hörl
Methylenetetrahydrofolate reductase gene polymorphisms in essential hypertension relation: with the development of hypertensive end-stage renal disease.
American journal of hypertension 2005;18(11):1442-8.
2005: Leszek Tylicki; Boleslaw Rutkowski
Metabolic disturbances as strong determinator of kidney injury in essential hypertension.
Journal of hypertension 2005;23(7):1433-4.
2005: Leszek Tylicki; Marcin Renke; Przemyslaw Rutkowski; Boleslaw Rutkowski; Wiesława Lysiak-Szydłowska
Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis.
Medical science monitor : international medical journal of experimental and clinical research 2005;11(4):PI31-7.
2005: Marcin Renke; Leszek Tylicki; Przemyslaw Rutkowski; Klaudiusz Wojnarowski; Wieslawa Lysiak-Szydlowska; Boleslaw Rutkowski
Low-dose dual blockade of the renin-angiotensin system improves tubular status in non-diabetic proteinuric patients.
Scandinavian journal of urology and nephrology 2005;39(6):511-7.
2005: Leszek Tylicki; Wojciech Larczynski; Boleslaw Rutkowski
Renal protective effects of the renin-angiotensin-aldosterone system blockade: from evidence-based approach to perspectives.
Kidney & blood pressure research 2005;28(4):230-42.
2004: Leszek Tylicki; Bogdan Biedunkiewicz; Dominik Rachon; Tomasz Nieweglowski; Lukasz Hak; Andrzej Chamienia; Alicja Debska-Slizien; Ewa Aleksandrowicz; Jolanta Mysliwska; Boleslaw Rutkowski
No effects of ozonated autohemotherapy on inflammation response in hemodialyzed patients.
Mediators of inflammation 2004;13(5-6):377-80.
2004: Leszek Tylicki; Slawomir Lizakowski; Bogdan Biedunkiewicz; Anna Skibowska; Tomasz Nieweglowski; Andrzej Chamienia; Alicja Debska-Slizien; Boleslaw Rutkowski
Platelet function unaffected by ozonated autohaemotherapy in chronically haemodialysed patients.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2004;15(7):619-22.
2004: Bogdan Biedunkiewicz; Leszek Tylicki; Dominik Rachon; Lukasz Hak; Tomasz Nieweglowski; Andrzej Chamienia; Alicja Debska-Slizien; Jolanta Mysliwska; Boleslaw Rutkowski
Natural killer cell activity unaffected by ozonated autohemotherapy in patients with end-stage renal disease on maintenance renal replacement therapy.
The International journal of artificial organs 2004;27(9):766-71.
2004: Leszek Tylicki; Bogdan Biedunkiewicz; Tomasz Nieweglowski; Malgorzata Grabowska; Andrzej Chamienia; Alicja Debska Slizien; Boleslaw Rutkowski
Fistula function and dialysis adequacy during ozonotherapy in chronically hemodialyzed patients.
Artificial organs 2004;28(5):513-7.
2004: Leszek Tylicki; Boleslaw Rutkowki
Tubulointerstitial injury: early or late event in the pathogenesis of hypertensive nephropathy?
Kidney international 2004;65(5):1971-2; author reply 1972.
2004: Leszek Tylicki; Bogdan Biedunkiewicz; Tomasz Nieweglowski; Andrzej Chamienia; Alicja Debska Slizien; Joanna Luty; Wieslawa Lysiak-Szydlowska; Boleslaw Rutkowski
Ozonated autohemotherapy in patients on maintenance hemodialysis: influence on lipid profile and endothelium.
Artificial organs 2004;28(2):234-7.
2004: Przemyslaw Rutkowski; Leszek Tylicki; Marcin Renke; Grzegorz Korejwo; Zbigniew Zdrojewski; Boleslaw Rutkowski
Low-dose dual blockade of the renin-angiotensin system in patients with primary glomerulonephritis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;43(2):260-8.
2004: Marcin Renke; Leszek Tylicki; Przemyslaw Rutkowski; Boleslaw Rutkowski
Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis.
Scandinavian journal of urology and nephrology 2004;38(5):427-33.
2004: Bogdan Biedunkiewicz; Leszek Tylicki; Tomasz Nieweglowski; S Burakowski; Boleslaw Rutkowski
Clinical efficacy of ozonated autohemotherapy in hemodialyzed patients with intermittent claudication: an oxygen-controlled study.
The International journal of artificial organs 2004;27(1):29-34.
2003: Boleslaw Rutkowski; Leszek Tylicki; Alicja Debska-Slizień
[Pathogenetic and epidemiological aspects of hypertensive nephropathy].
Polskie Archiwum Medycyny Wewnętrznej 2003;110(4):1167-71.
2003: Bogdan Biedunkiewicz; Leszek Tylicki; Monika Lichodziejewska-Niemierko; Tomasz Liberek; Boleslaw Rutkowski
Ozonetherapy in a dialyzed patient with calcific uremic arteriolopathy.
Kidney international 2003;64(1):367-8.
2003: Leszek Tylicki; Tomasz Nieweglowski; Bogdan Biedunkiewicz; Andrzej Chamienia; Alicja Debska-Slizien; Ewa Aleksandrowicz; Wieslawa Lysiak-Szydlowska; Boleslaw Rutkowski
The influence of ozonated autohemotherapy on oxidative stress in hemodialyzed patients with atherosclerotic ischemia of lower limbs.
The International journal of artificial organs 2003;26(4):297-303.
2003: Leszek Tylicki; Jacek Manitius; Wiesława Łysiak-Szydłowska; Boleslaw Rutkowski
Tubular injury: the first symptom of hypertensive kidney involvement?
Medical science monitor : international medical journal of experimental and clinical research 2003;9(4):CR135-41.
2003: Leszek Tylicki; Antje Habicht; Bruno Watschinger; Walter H Hörl
Treatment of hypertension in renal transplant recipients.
Current opinion in urology 2003;13(2):91-8.
2003: Leszek Tylicki; Boleslaw Rutkowski
[Hypertensive nephropathy: pathogenesis, diagnosis and treatment].
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 2003;14(80):168-73.
2003: Leszek Tylicki; Boleslaw Rutkowski; Walter H Hörl
Antioxidants: a possible role in kidney protection.
Kidney & blood pressure research 2003;26(5-6):303-14.
2002: Leszek Tylicki; Przemyslaw Rutkowski; Marcin Renke; Boleslaw Rutkowski
Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.
American journal of nephrology 2002;22(4):356-62.
2002: Leszek Tylicki; Marcin Renke; Przemyslaw Rutkowski; Boleslaw Rutkowski
Short-term effects of angiotensin II receptor blockade in patients with primary glomerulonephritis: pilot study.
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 2002;12(2):122-5.
2002: Leszek Tylicki; Boleslaw Rutkowski; Walter H Hörl
Multifactorial determination of hypertensive nephroangiosclerosis.
Kidney & blood pressure research 2002;25(6):341-53.
2001: Leszek Tylicki; T Niew głowski; Bogdan Biedunkiewicz; S Burakowski; Boleslaw Rutkowski
Beneficial clinical effects of ozonated autohemotherapy in chronically dialysed patients with atherosclerotic ischemia of the lower limbs--pilot study.
The International journal of artificial organs 2001;24(2):79-82.
2000: Boleslaw Rutkowski; A Wielgosz; Jacek Manitius; B Bułło; J Kowalewska; Leszek Tylicki; A Roszkiewicz
[Cyclophosphamide pulse therapy in patients with primary glomerulonephritis].
Przegla̧d lekarski 2000;57(11):624-7.
1999: Boleslaw Rutkowski; Leszek Tylicki; Jacek Manitius; Wieslawa Lysiak-Szydlowska
Hypertensive nephropathy - an increasing clinical problem.
Mineral and electrolyte metabolism 1999;25(1-2):65-8.